Futura Medical Share Chat (FUM)

£2 - Yes please - sold to the man in the suit - Thank and bank

BOOM - not often you can say that in FUM

£1.06 with high volumes.
FAB

could go up to £2.00 per share
From The Mail Online :
Shares of the AIM-listed healthcare firm, which is sitting on two potentially explosive products in the sexual enhancement field, rose 2.5p to 101p on hot gossip that Reckitt Benckiser and Australia’s Ansell are both willing to pay up to £2 a share to gain full control of the Surrey-based company.
They would love to get their hands on Futura’s most exciting new prospect

...... now available for download.
FAG

Take-over talks mentioned in the Daily Telegraph should help stabilise the SP and could push it significantly higher.

Got a decent mention in the Motley Fool today

"PET500 will be marketed as part of Ansell's LifeStyles® brand and it is expected that it will be launched from July in a phased roll-out throughout the USA. We expect recurring royalty income to begin to flow this year but as the launch is phased the initial royalties are likely to be relatively modest."

http://www.futuramedical.co.uk/content/financial/financial_results.asp

Wonder if we'll have a launch date for CSD500 by then!?

I joined Futura after more than 35 years at GlaxoSmithKline, most recently as the President of its Consumer Healthcare division. My executive career has given me considerable experience of the consumer healthcare sector, which I believe is reliant on one thing: innovation.
Futura is a company with innovation at its core. It also has a great team of people, which it is a privilege for me to join. Its DermaSys® delivery system is at the forefront of transdermal drug delivery, a delivery route that is particularly appealing for OTC products. DermaSys® creates the opportunity for Futura to develop organically into a substantial business.
It is my intention to help Futura realise the full potential of its market opportunities whilst also using my experience of global companies to assist in its licensing strategy.
2012 promises to be a very exciting year for Futura with two products close to launch and a pipeline of further opportunities at various stages of development. I look forward to contributing to the Company's success.

John Clarke
Chairman